葡萄牙全国范围内复杂肾下型、近肾型及肾旁型腹主动脉瘤开放手术与腔内修复的结局比较
该回顾性队列研究基于葡萄牙国家血管手术登记数据库,纳入2019至2023年间16个中心治疗的293例完整复杂腹主动脉瘤患者,比较开放手术(OSR)、开窗分支腔内修复(FB-EVAR)及辅助/超适应证腔内修复(EVAR)的30天不良事件与主要不良事件。腔内策略占67.9%,EVAR与FB-EVAR相较OSR的AE及MAE风险更低,但死亡率与救治失败率无显著差异,一年生存与再干预可比。
要点
- 与OSR相比,EVAR的AE风险aOR 0.17(0.08-0.40),MAE风险aOR 0.10(0.04-0.29)。
- 与OSR相比,FB-EVAR的AE风险aOR 0.44(0.21-0.91),MAE风险aOR 0.42(0.19-0.91)。
- 低容量中心FB-EVAR后并发症发生率33.3% vs 12.3%,p=0.040。
核心结论
- 全国数据显示复杂腹主动脉瘤治疗实践存在显著差异,腔内策略总体与更好的早期结局相关,但一年结局可比。
- 作者指出解读这些结果应谨慎,需考虑治疗选择偏倚的可能性。
研究设计与样本
- 回顾性队列研究,使用覆盖葡萄牙多数血管中心的前瞻性人群基础登记数据库(葡萄牙国家血管手术登记)。
- 纳入2019至2023年间16个中心治疗的293例完整复杂腹主动脉瘤(近肾型、肾旁型或复杂肾下颈超出EVAR适应证)患者。
- 按手术技术分层为开放手术(OSR)、开窗分支腔内修复(FB-EVAR)或辅助/超适应证EVAR,采用逆概率加权评估结局。
- 各中心中位病例量为11例(范围1-93,其中OSR 0-19;EVAR 0-34;FB-EVAR 0-40)。
主要发现
- 腔内策略占67.9%(FB-EVAR 32.7%;EVAR 35.2%)。
- 与OSR相比,腔内组年龄更大、肺部合并症更常见;与EVAR相比,FB-EVAR患者更年轻且既往主动脉修复比例更高。
- 与OSR相比,EVAR的AE风险aOR 0.17(0.08-0.40),MAE风险aOR 0.10(0.04-0.29)。
- 与OSR相比,FB-EVAR的AE风险aOR 0.44(0.21-0.91),MAE风险aOR 0.42(0.19-0.91)。
- 死亡率(aOR 0.40,0.11-1.25)与救治失败(aOR 1.70,0.33-8.87)差异无统计学意义。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出解读结果应谨慎,需考虑治疗选择偏倚的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Data on complex abdominal aortic aneurysms (cAAAs) are scarce in Portugal. The authors aimed to assess the outcomes of endovascular and open surgical repair (OSR) for cAAAs using the Portuguese National Registry of Vascular Procedures, which is a prospective population based registry covering most of Portugal's vascular centres. METHODS: This retrospective cohort study included patients treated for intact cAAA (juxtarenal, pararenal, or complex infrarenal necks outside instructions for use [IFU] for endovascular aneurysm repair [EVAR]). Patients were stratified by surgical technique (OSR, fenestrated and branched [FB-EVAR], or EVAR with adjuncts and or outside IFU). The primary endpoints were 30 day adverse events (AEs) and major adverse events (MAEs). Secondary endpoints were death, failure to rescue, and practice patterns. Outcomes were assessed using inverse probability weighting. RESULTS: From 2019 to 2023, 293 patients were identified and treated in 16 centres with a median caseload of 11 (range 1 - 93, of which OSR 0 - 19; EVAR 0 - 34, and FB-EVAR 0 - 40). Endovascular strategies were performed in 67.9% (32.7% FB-EVAR; 35.2% EVAR). Compared with OSR, the endovascular group was older, with more frequent pulmonary comorbidities. Compared with EVAR, patients having FB-EVAR were younger and more likely to have had a previous aortic repair. Compared with OSR, EVAR had a lower risk of AEs (adjusted odds ratio [aOR] 0.17, 0.08 - 0.40) and MAEs (aOR 0.10, 0.04 - 0.29). Similarly, FB-EVAR had a lower risk of AEs (aOR 0.44, 0.21 - 0.91) and MAEs (aOR 0.42, 0.19 - 0.91). Non-significant differences in mortality rate (aOR 0.40, 0.11 - 1.25) and failure to rescue (aOR 1.70, 0.33 - 8.87) were observed. Increased morbidity following FB-EVAR was noted in low volume centres (33.3% vs. 12.3%, p = .040). One year survival and secondary interventions (available for 45.5% of cases) were comparable between strategies. CONCLUSION: Nationwide data on the treatment of cAAA revealed significant variability in practice. Endovascular strategies were generally associated with improved early outcomes compared with OSR, but one year outcomes were comparable. These results should be interpreted with caution, considering the likelihood of bias in treatment selection.
引用
- Ribeiro TF, Quintas A, Soares Ferreira R, et al. Nationwide Outcomes of Open versus Endovascular Repair for Complex Infrarenal Neck, Juxtarenal, and Pararenal Abdominal Aortic Aneurysm in Portugal. Eur J Vasc Endovasc Surg. 2025. PMID: 40288565. doi:10.1016/j.ejvs.2025.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。